Hyeyeong Kim
Ulsan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
The Role of Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer with Microsatellite Instability-High or DNA Mismatch Repair Deficiencies: A Multicenter Pooled Analysis (KCSG-CO24-03).
Journal: Cancer research and treatment
Published: February 14, 2026
Impact of unmet needs on health-related quality of life among cancer survivors in Ulsan, Korea.
Journal: BMC cancer
Published: December 24, 2025
Efficacy of Nivolumab plus Ipilimumab in Advanced Hepatocellular Carcinoma with and without High-Risk Features: An International Multicenter Study.
Journal: Liver cancer
Published: December 05, 2025
Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features.
Journal: Clinical and molecular hepatology
Published: July 17, 2025
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: July 14, 2025
Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab.
Journal: Journal of hepatology
Published: May 10, 2025
Organ-Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study.
Journal: Cancer medicine
Published: April 06, 2025
Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study.
Journal: Future oncology (London, England)
Published: September 25, 2024
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries.
Journal: Liver cancer
Published: March 29, 2024
Distinct Characteristics and Changes in Liver Function of Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab for More Than 1 Year.
Journal: Cancer research and treatment
Published: March 04, 2024
Effectiveness of self-reported management program of cancer patients.
Journal: Digital health
Published: December 26, 2023
Catastrophizing Maladaptive Coping Affects the Association Between Viral Anxiety and Fear of Progression in Cancer Patients During COVID-19 Pandemic.
Journal: Psychiatry investigation
Published: September 24, 2023
Last Updated: 09/26/2026